Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
17
02
2021
accepted:
23
12
2021
pubmed:
29
1
2022
medline:
23
8
2022
entrez:
28
1
2022
Statut:
epublish
Résumé
Cystic fibrosis (CF) is a monogenic life-shortening disease associated with highly variable individual disease progression which is difficult to predict. Here we assessed the association of forskolin-induced swelling (FIS) of patient-derived organoids with long-term CF disease progression in multiple organs and compared FIS with the golden standard biomarker sweat chloride concentration (SCC). We retrieved 9-year longitudinal clinical data from the Dutch CF Registry of 173 people with mutations in the cystic fibrosis transmembrane conductance regulator ( FIS was strongly associated with longitudinal changes of lung function, with an estimated difference in annual FEV This study exemplifies the prognostic value of a patient-derived organoid-based biomarker within a clinical setting, which is especially important for people carrying rare
Identifiants
pubmed: 35086832
pii: 13993003.00508-2021
doi: 10.1183/13993003.00508-2021
pmc: PMC9386333
pii:
doi:
Substances chimiques
Biomarkers
0
Cystic Fibrosis Transmembrane Conductance Regulator
126880-72-6
Colforsin
1F7A44V6OU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright ©The authors 2022.
Déclaration de conflit d'intérêts
Conflict of interest: J.M. Beekman reports personal fees from Vertex Pharmaceuticals, Proteostasis Therapeutics, Eloxx Pharmaceuticals, Teva Pharmaceutical Industries and Galapagos, outside the submitted work; in addition, J.M. Beekman has a patent related to the FIS-assay with royalties paid. C.K. van der Ent reports grants from GSK, Nutricia, TEVA, Gilead, Vertex, ProQR, Proteostasis, Galapagos NV and Eloxx, outside the submitted work; in addition, C.K. van der Ent has a patent 10006904 with royalties paid. G.H. Koppelman reports grants from Lung Foundation of the Netherlands, Vertex Pharmaceuticals, UBBO EMMIUS foundation, GSK, TEVA the Netherlands, TETRI Foundation and European Union (H2020), outside the submitted work; and has participated in advisory board meetings for GSK and PURE-IMS outside the submitted work (money paid to institution). P. van Mourik reports financial compensation (money to institution) from Vertex for participation in a webinar, outside the submitted work. All other authors have nothing to disclose.
Références
Ann Am Thorac Soc. 2021 Mar;18(3):433-441
pubmed: 33095038
J Cyst Fibros. 2021 Sep;20(5):761-767
pubmed: 33249003
Lancet. 1990 Nov 3;336(8723):1081-4
pubmed: 1977977
Eur Respir J. 2013 Jan;41(1):203-16
pubmed: 22878883
Sci Transl Med. 2016 Jun 22;8(344):344ra84
pubmed: 27334259
J Cyst Fibros. 2014 Jul;13(4):363-72
pubmed: 24882694
Eur Respir J. 2018 Sep 17;52(3):
pubmed: 30166324
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
J Cyst Fibros. 2021 Jan;20(1):86-90
pubmed: 32381400
J Cyst Fibros. 2017 Mar;16(2):239-245
pubmed: 27745801
Lancet. 2003 May 17;361(9370):1671-6
pubmed: 12767731
STAR Protoc. 2020 Jun 03;1(1):100019
pubmed: 33111074
Pediatr Pulmonol. 2004 Sep;38(3):204-9
pubmed: 15274098
Eur Respir J. 2021 Jan 5;57(1):
pubmed: 32747394
Gastroenterology. 2000 Jul;119(1):32-40
pubmed: 10889152
Gastroenterology. 2004 Jan;126(1):32-41
pubmed: 14699484
Lancet. 2016 Nov 19;388(10059):2519-2531
pubmed: 27140670
Chest. 2006 Nov;130(5):1441-7
pubmed: 17099022
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1375-1382
pubmed: 27258095
Mol Biol Cell. 2016 Feb 1;27(3):424-33
pubmed: 26823392
J Cyst Fibros. 2020 Jul;19(4):614-619
pubmed: 31735562
Nat Med. 2013 Jul;19(7):939-45
pubmed: 23727931
Nat Rev Genet. 2015 Jan;16(1):45-56
pubmed: 25404111
J Pediatr. 2010 Nov;157(5):802-7.e1-3
pubmed: 20580019
Am J Respir Crit Care Med. 2020 Dec 1;202(11):1589-1592
pubmed: 32687398
BMJ Open Respir Res. 2020 Oct;7(1):
pubmed: 33020115
Front Pharmacol. 2013 Apr 23;4:40
pubmed: 23630497
J Cyst Fibros. 2020 Jul;19(4):620-626
pubmed: 31699569
Cell Rep. 2019 Feb 12;26(7):1701-1708.e3
pubmed: 30759382